Front Page

Previous Story

Next Story

NIH Record

Past, Current Directors Speak at NIAID's 50th Anniversary

Advancing Knowledge and Improving Health" is the theme of NIAID's 50th anniversary scientific symposium to be held on Thursday, Nov. 19 from 9 a.m. to 5 p.m. in Natcher Conference Center auditorium. All NIH staff are invited. Distinguished investigators from NIH and elsewhere will speak about current knowledge and future research goals of the major emphasis areas supported by NIAID -- allergy, immunology and infectious diseases.

NIH deputy director Dr. Ruth Kirschstein will open the event with welcoming remarks. NIAID director Dr. Anthony Fauci will then give a historical perspective of the institute's research accomplishments. Dr. Richard Krause, senior scientific advisor of the Fogarty International Center and immediate past NIAID director, will speak on "Microbes Evolving and Emerging Infectious Diseases: The Compulsion to Become Something New." Following Krause, Dr. Jeffrey Bluestone, the Virginia and D.K. Ludwig professor at the University of Chicago, will address "Organ-Specific Tolerance: Achieving the Holy Grail of Transplantation!" The morning program will end with Dr. Robert Gallo, director of the University of Maryland's Institute of Human Virology in Baltimore, giving a personal perspective on HIV/AIDS research.

Dr. Richard Krause (l), NIAID's fourth director (August 1975-July 1984) appears in this 1988 photograph with the institute's fifth and present director, Dr. Anthony Fauci.

After lunch, Dr. Max Cooper, an investigator with the Howard Hughes Medical Research Institute and a professor of medicine, pediatrics, pathology and microbiology at the University of Alabama at Birmingham, will lecture on "Immune System Development and Human Well-Being," followed by Dr. Louis H. Miller, chief of NIAID's Laboratory of Parasitic Diseases, who will discuss "The Modern Pasteurians: From Science to Control and Eradication of Malaria." The program will close with Dr. K. Frank Austin, professor of medicine at Harvard University, who will address "The Biosynthesis of the Cysteinyl Leukotrienes, Mediators of Bronchial Asthma," and Dr. R. Gordon Douglas, Jr., president of Merck Vaccines, who will talk about "The Future of Vaccines: Science, Public Health and Medicine."

No registration is required. Seating is available on a first-come, first-served basis. For more information, call 496-5717.


Up to Top